Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
Lisa Rider, MD
Garrett Park, MD, United States
Disclosure(s): Bristol-Myers Squibb(BMS): Grant/Research Support (Ongoing); Eli Lilly: Grant/Research Support (Terminated, December 31, 2020); Hope Pharmaceuticals: Grant/Research Support (Ongoing)
Faculty will review the latest research on idiopathic inflammatory myopathies, highlighting distinct mechanisms implicated in different forms of myositis. Implications for muscle deterioration, cancer, and potential novel therapies will also be highlighted.
Speaker: Livia Casciola-Rosen, PhD – Johns Hopkins University
Speaker: Shinsuke Yasuda, MD – Tokyo Medical and Dental University
Speaker: Thomas E. Lloyd, MD, PhD – Johns Hopkins University School of Medicine